Description
A spiroketal antibiotic that inhibits EGF mitogenic activity, displays antiproliferative activity against human tumor cells, and demonstrates antifungal activity; inhibits bone resorption by inducing apoptosis in osteoclasts with an IC50 value of 0.7 µM
Formal name: butanedioic acid, 1-[(2S,3R,6S,8R,9S)-3-butyl-8-[(2E,4E,6S,7S,8E)-9-carboxy-6-hydroxy-3,7-dimethyl-2,4,8-nonatrien-1-yl]-2-[(1E,3E)-4-carboxy-3-methyl-1,3-butadien-1-yl]-9-methyl-1,7-dioxaspiro[5.5]undec-3-yl] ester
Synonyms:
Molecular weight: 660.8
CAS: 134615-37-5
Purity: ≥99%
Formulation: A lyophilisate
Product Type|Biochemicals|Antifungals||Product Type|Biochemicals|Natural Products|Microbial Metabolites||Research Area|Cancer||Research Area|Endocrinology & Metabolism|Bone Growth & Remodeling||Research Area|Immunology & Inflammation||Research Area|Infectious Disease|Fungal Diseases|Candidiasis